Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-040291

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fleming Harold Edward Director 2021-06-10 Grant or award · Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X03/doc4.xml…